Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...
Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...
Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs.
Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...
Swim Across America, a national nonprofit dedicated to funding cancer research and patient programs through funds raised with charity swims, is pleased to announce the appointment of two distinguished ...
Toast , the digital technology platform built for hospitality, has signed an agreement with Ascent Hospitality Management to implement Toast Enterprise Solutions at Perkins American Food Co. and ...
Gene Mack, Gain Therapeutics CEO, provides a look into the future of the company and the use of physics-based artificial ...
In a challenging year for biotech firms, Ideaya Biosciences Inc . (NASDAQ:IDYA) stock has reached a 52-week low, touching down at $21.02. According to InvestingPro data, the company maintains strong ...
By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback